We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInt.biotech. Regulatory News (IBT)

Share Price Information for Int.biotech. (IBT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 616.00
Bid: 608.00
Ask: 616.00
Change: 10.00 (1.65%)
Spread: 8.00 (1.316%)
Open: 612.00
High: 616.00
Low: 612.00
Prev. Close: 606.00
IBT Live PriceLast checked at -
International Biotechnology is an Investment Trust

To achieve capital growth through investing in high growth, development stage biotechnology companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Kepler Trust Intelligence: New Research

20 Mar 2024 18:31

RNS Number : 6881H
Intl. Biotechnology Trust PLC
20 March 2024
 

International Biotechnology: New Research

20/03/2024

Ailsa Craig and Marek Poszepczynski are celebrating their first three years as managers of IBT?

The investment companies team at Kepler Trust Intelligence has produced a new piece of investment bank quality research about the trust, designed to provide a clear and comprehensive reference for long term investors. This note is free to read for UK investors.

Click here to read the note in full.

 

Visit http://www.trustintelligence.co.uk/investor for more high-quality investment trust research.

 

Important information

This report has been issued by Kepler Partners LLP. The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 70 Conduit Street, London W1S 2GF with registered number OC334771.

Visit http://www.trustintelligence.co.uk/investor for more high-quality investment trust research.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEAPDEAAXLEFA
Date   Source Headline
26th Apr 202410:43 amRNSNet Asset Value(s)
25th Apr 20244:17 pmRNSTransaction in Own Shares
25th Apr 202410:41 amRNSNet Asset Value(s)
24th Apr 20245:32 pmRNSTransaction in Own Shares
24th Apr 202410:24 amRNSNet Asset Value(s)
23rd Apr 20243:40 pmRNSTransaction in Own Shares
23rd Apr 202411:04 amRNSNet Asset Value(s)
22nd Apr 20244:29 pmRNSTransaction in Own Shares
22nd Apr 202410:32 amRNSNet Asset Value(s)
19th Apr 20245:10 pmRNSTransaction in Own Shares
19th Apr 202410:12 amRNSNet Asset Value(s)
18th Apr 20245:06 pmRNSTransaction in Own Shares
18th Apr 202410:17 amRNSNet Asset Value(s)
17th Apr 20243:35 pmRNSTransaction in Own Shares
17th Apr 202410:35 amRNSNet Asset Value(s)
16th Apr 20245:33 pmRNSTransaction in Own Shares
16th Apr 202410:33 amRNSNet Asset Value(s)
15th Apr 20244:23 pmRNSTransaction in Own Shares
15th Apr 202411:33 amRNSNet Asset Value(s)
12th Apr 20244:29 pmRNSTransaction in Own Shares
12th Apr 202410:48 amRNSNet Asset Value(s)
11th Apr 20243:48 pmRNSTransaction in Own Shares
11th Apr 202410:25 amRNSNet Asset Value(s)
10th Apr 20245:17 pmRNSTransaction in Own Shares
10th Apr 202410:22 amRNSNet Asset Value(s)
9th Apr 20245:16 pmRNSTransaction in Own Shares
9th Apr 202411:03 amRNSNet Asset Value(s)
8th Apr 20244:42 pmRNSTransaction in Own Shares
8th Apr 202411:17 amRNSNet Asset Value(s)
5th Apr 202411:20 amRNSCompliance with Market Abuse Regulations
5th Apr 202410:22 amRNSNet Asset Value(s)
4th Apr 20244:51 pmRNSTransaction in Own Shares
4th Apr 202410:55 amRNSNet Asset Value(s)
3rd Apr 20245:14 pmRNSTransaction in Own Shares
3rd Apr 202410:32 amRNSNet Asset Value(s)
2nd Apr 20244:08 pmRNSTransaction in Own Shares
2nd Apr 202411:09 amRNSNet Asset Value(s)
28th Mar 20245:15 pmRNSTotal Voting Rights
28th Mar 20245:05 pmRNSTransaction in Own Shares
28th Mar 202411:06 amRNSNet Asset Value(s)
27th Mar 20245:02 pmRNSTransaction in Own Shares
27th Mar 202410:54 amRNSNet Asset Value(s)
26th Mar 202411:24 amRNSNet Asset Value(s)
25th Mar 202411:16 amRNSNet Asset Value(s)
22nd Mar 20245:10 pmRNSTransaction in Own Shares
22nd Mar 20244:54 pmRNSLatest Factsheet and Blog
22nd Mar 202410:28 amRNSNet Asset Value(s)
21st Mar 20245:00 pmRNSTransaction in Own Shares
21st Mar 202410:19 amRNSNet Asset Value(s)
20th Mar 20246:31 pmRNSKepler Trust Intelligence: New Research

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.